Mithramycin

Jump to navigation Jump to search

WikiDoc Resources for Mithramycin

Articles

Most recent articles on Mithramycin

Most cited articles on Mithramycin

Review articles on Mithramycin

Articles on Mithramycin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mithramycin

Images of Mithramycin

Photos of Mithramycin

Podcasts & MP3s on Mithramycin

Videos on Mithramycin

Evidence Based Medicine

Cochrane Collaboration on Mithramycin

Bandolier on Mithramycin

TRIP on Mithramycin

Clinical Trials

Ongoing Trials on Mithramycin at Clinical Trials.gov

Trial results on Mithramycin

Clinical Trials on Mithramycin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mithramycin

NICE Guidance on Mithramycin

NHS PRODIGY Guidance

FDA on Mithramycin

CDC on Mithramycin

Books

Books on Mithramycin

News

Mithramycin in the news

Be alerted to news on Mithramycin

News trends on Mithramycin

Commentary

Blogs on Mithramycin

Definitions

Definitions of Mithramycin

Patient Resources / Community

Patient resources on Mithramycin

Discussion groups on Mithramycin

Patient Handouts on Mithramycin

Directions to Hospitals Treating Mithramycin

Risk calculators and risk factors for Mithramycin

Healthcare Provider Resources

Symptoms of Mithramycin

Causes & Risk Factors for Mithramycin

Diagnostic studies for Mithramycin

Treatment of Mithramycin

Continuing Medical Education (CME)

CME Programs on Mithramycin

International

Mithramycin en Espanol

Mithramycin en Francais

Business

Mithramycin in the Marketplace

Patents on Mithramycin

Experimental / Informatics

List of terms related to Mithramycin


Mithramycin is an anti-neoplastic antibiotic. Its major use is as an IV infusion to reduce very high levels of plasma calcium. It inhibits RNA synthesis in osteoclasts. Typically use a dose of 25 microgram per kilogram IV given over four to six hours. This dose can be repeated in 1 to 2 days if necessary. Ca++ levels start falling after 12 hours, with maximal reduction at 48-72 hours.

Hypercalcaemia recurs in days to several weeks. With repeated use, organotoxicity (kidney, liver, haematopoetic system) can become a problem. Template:WH Template:WikiDoc Sources